Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
| Status: | Terminated |
|---|---|
| Healthy: | No |
| Age Range: | 30 - 60 |
| Updated: | 4/17/2018 |
| Start Date: | November 2012 |
| End Date: | November 2015 |
A Prospective Study of the Use of Micropulse 577nm Laser Treatment in Central Serous Chorioretinopathy
The investigators hypothesis is that using the micropulse laser in patient with Central
Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in
significantly minimizing visual recovery time from this disease as well as potentially
preventing recurrences.
Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in
significantly minimizing visual recovery time from this disease as well as potentially
preventing recurrences.
The investigators hypothesize that application of 577nm micropulse laser in patients with CSC
will prompt resolution of CSC as measured by ocular coherence tomography and best corrected
visual acuity. This will be a pilot study to establish sound methods and provide some
insights to the safety and efficacy of CSC treatment.
will prompt resolution of CSC as measured by ocular coherence tomography and best corrected
visual acuity. This will be a pilot study to establish sound methods and provide some
insights to the safety and efficacy of CSC treatment.
Inclusion Criteria:
- Patients with new diagnosis of CSC and no other comorbidities or prior retinal
treatment
- Patients ranging from 30 to 60 years of age
Exclusion Criteria:
- Patients with no case of CSC
- Patients with other macular comorbidities including but not limited to diabetic
retinopathy, macular degeneration
- Patients with prior retinal treatment
We found this trial at
1
site
Click here to add this to my saved trials
